Benevolence About Kidney-Related Disorders And Diabetes To Drive The Diabetic Nephropathy Market

Persistence Market Research (PMR), with its latest report named “Diabetic Nephropathy Market: Global Industry Analysis 2017-2027”, gives a detailed analysis about diabetic nephropathy market in the form of the factors influencing it under the gambit of strengths, weaknesses, opportunities, threats, and trends with 2017, 2028, and 2019 being the historical years and period from 2020 to 2027 being the forecast one.

Market Report Summary 

• Market – Diabetic Nephropathy Market 
• Market Value – USD 3,145.9 Million in 2021 
• Market CAGR Value – 5.6% in 2021 
• Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

According to a new market report published by Persistence Market Research “Global Market Study on Diabetic Nephropathy Market – Asia to Witness Highest Growth by 2020,”.The global diabetic nephropathy market was valued at USD 2,262.2 million in 2014 and is expected to grow at a CAGR of 5.6% from 2014 to 2020, to reach an expected value of USD 3,145.9 million in 2020.

Diabetic nephropathy is a disease of the kidney glomerulus and one of the most significant complications in terms of mortality and morbidity for patients with diabetes. Globally, the diabetic nephropathy market is witnessing significant growth due to increasing prevalence of diabetes and obesity in different regions of the world. In addition, increasing R&D investments in drug discovery and development and raising awareness about diabetes and kidney-related disorders are also driving the growth of the market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3594

Some of the major players in the diabetic nephropathy market:

• Novartis AG, Merck & Co., Inc.
• Pfizer, Inc.
• Abbott Laboratories.
• Sanofi.
• Eli Lilly.
• Company.
• Reata Pharmaceuticals, Inc.
• Bayer AG, AbbVie, Inc.
• Mitsubishi Tanabe Pharma Corporation

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3594

However, stringent regulatory requirements and longer approval time for drugs as well as the lack of comprehensive therapeutic management for diabetic nephropathy are inhibiting the growth of diabetic nephropathy market. The global diabetic nephropathy market is estimated at USD 2,262.2 million in 2014. It is likely to grow at a CAGR of 5.6% from 2014 to 2020 to reach USD 3,145.9 million in 2020.

In North America, various government programs are spreading awareness about diabetes and related renal complications. For instance, the National Kidney Disease Education Program, one of the major programs organized by the U.S. government, for increasing awareness about the various kidney diseases. In addition, the number of diabetic patients are also increasing in the region; according to the SciELO Public Health, approximately 35 million people were affected with diabetes mellitus in 2000 and this number is expected to reach 64 million by 2025 in North America.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3594

In Europe, rise in healthcare expenditure for diabetes treatment and increasing prevalence of diabetes in the various part of Europe is boosting the growth of the European diabetic nephropathy market. According to IDF, approximately 55.4 million people had diabetes in 2010 and the number is expected to reach 66.5 million by 2030 in Europe. According to the IDF, healthcare expenditure for diabetes treatment was approximately USD 105.5 billion in 2010 and is expected to reach USD 124.6 billion by 2030 in Europe.

Asia represents the fastest growing region in the diabetic nephropathy market due to the rise in a diabetic population in various countries such as Japan and the Southeast Asian countries. According to the International Diabetes Federation (IDF), developing countries, such as India and China, are expected to have the highest number of diabetes mellitus patients compared to developed countries, such as the U.S. and Germany.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Source MARKITWIRED